Utility of 2-year kidney failure risk equation for advanced chronic kidney disease: analysis from the STOP-ACEi trial

Sunil Bhandari; Samir Mehta; Natalie Rowland; Paul Cockwell

doi:10.1093/ndt/gfad263

Utility of 2-year kidney failure risk equation for advanced chronic kidney disease: analysis from the STOP-ACEi trial

Sunil Bhandari^*, Samir Mehta, Natalie Rowland, Paul Cockwell

^*Corresponding author for this work

Birmingham Clinical Trials Unit

Research output: Contribution to journal › Letter › peer-review

Original language	English
Article number	gfad263
Number of pages	4
Journal	Nephrology, Dialysis, Transplantation
Early online date	19 Dec 2023
DOIs	https://doi.org/10.1093/ndt/gfad263
Publication status	E-pub ahead of print - 19 Dec 2023

Bibliographical note

FUNDING
This study is funded by a grant from The National Institute for Health Research and the Medical Research Council (grant number: NIHR-HTA 11/30/07. STOP ACEi EudraCT number, 2013-003798-82; ISRCTN number, 62869767).

Keywords

angiotensin-converting enzyme inhibitors
Kidney failure
chronic kidney failure

Access to Document

10.1093/ndt/gfad263Licence: None: All rights reserved

STOP-ACEi - Multi-Centre Randomised Controlled Trial of Angiotensin Converting Enzyme inhibitor (ACE-i)/Angiotensin Receptor Blocker (ARB) withdrawl in advanced renal disease
Rowland, N.
NIHR EVALUATION, TRIALS AND STUDIES COORDINATING CENTRE
1/04/14 → 31/12/21
Project: Other Government Departments

Cite this

@article{6a2529e946614ef590a1699c8ff45efb,

title = "Utility of 2-year kidney failure risk equation for advanced chronic kidney disease: analysis from the STOP-ACEi trial",

keywords = "angiotensin-converting enzyme inhibitors, Kidney failure, chronic kidney failure",

author = "Sunil Bhandari and Samir Mehta and Natalie Rowland and Paul Cockwell",

note = "FUNDING This study is funded by a grant from The National Institute for Health Research and the Medical Research Council (grant number: NIHR-HTA 11/30/07. STOP ACEi EudraCT number, 2013-003798-82; ISRCTN number, 62869767).",

year = "2023",

month = dec,

day = "19",

doi = "10.1093/ndt/gfad263",

language = "English",

journal = "Nephrology, Dialysis, Transplantation",

issn = "0931-0509",

publisher = "Oxford University Press",

}

TY - JOUR

T1 - Utility of 2-year kidney failure risk equation for advanced chronic kidney disease

T2 - analysis from the STOP-ACEi trial

AU - Bhandari, Sunil

AU - Mehta, Samir

AU - Rowland, Natalie

AU - Cockwell, Paul

N1 - FUNDING This study is funded by a grant from The National Institute for Health Research and the Medical Research Council (grant number: NIHR-HTA 11/30/07. STOP ACEi EudraCT number, 2013-003798-82; ISRCTN number, 62869767).

PY - 2023/12/19

Y1 - 2023/12/19

KW - angiotensin-converting enzyme inhibitors

KW - Kidney failure

KW - chronic kidney failure

U2 - 10.1093/ndt/gfad263

DO - 10.1093/ndt/gfad263

M3 - Letter

SN - 0931-0509

JO - Nephrology, Dialysis, Transplantation

JF - Nephrology, Dialysis, Transplantation

M1 - gfad263

ER -

Utility of 2-year kidney failure risk equation for advanced chronic kidney disease: analysis from the STOP-ACEi trial

Bibliographical note

Keywords

Access to Document

Projects

STOP-ACEi - Multi-Centre Randomised Controlled Trial of Angiotensin Converting Enzyme inhibitor (ACE-i)/Angiotensin Receptor Blocker (ARB) withdrawl in advanced renal disease

Cite this